Acute Renal Failure (ARF) Global Market Report 2025

Acute Renal Failure (ARF) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute renal failure (arf) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for acute renal failure (arf) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute renal failure (arf) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Disease Type: Prerenal Acute Renal Failure; Renal Acute Renal Failure; Postrenal Acute Renal Failure

2) By Drug Type: Diuretics; Vasopressors; Erythropoiesis-Stimulating Agents (ESAS); Phosphate Binders; Calcium and Vitamin D Supplements; Antibiotics; Others Drugs

3) By Route of Administration: Oral; Intravenous

4) By Diagnosis: Computed Tomography (CT) Scan; Kidney Biopsy; Ultrasound

5) By End-Users: Clinics; Hospitals; Home Healthcare; Others End-Users

Subsegments:

1) By Prerenal Acute Renal Failure: Hypovolemia; Decreased Cardiac Output; Renal Artery Stenosis

2) By Renal Acute Renal Failure: Acute Tubular Necrosis; Glomerulonephritis; Interstitial Nephritis

3) By Postrenal Acute Renal Failure: Obstructive Uropathy; Bladder Outlet Obstruction; Kidney Stones

Companies Mentioned: Pfizer Inc.; Novartis AG; LG Chem Ltd.; Medtronic plc; Fresenius Medical Care AG & Co. KGaA

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Acute Renal Failure (ARF) Market Characteristics
3. Acute Renal Failure (ARF) Market Trends And Strategies
4. Acute Renal Failure (ARF) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Acute Renal Failure (ARF) Growth Analysis And Strategic Analysis Framework
5.1. Global Acute Renal Failure (ARF) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Acute Renal Failure (ARF) Market Growth Rate Analysis
5.4. Global Acute Renal Failure (ARF) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Acute Renal Failure (ARF) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Acute Renal Failure (ARF) Total Addressable Market (TAM)
6. Acute Renal Failure (ARF) Market Segmentation
6.1. Global Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prerenal Acute Renal Failure
Renal Acute Renal Failure
Postrenal Acute Renal Failure
6.2. Global Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diuretics
Vasopressors
Erythropoiesis-Stimulating Agents (ESAS)
Phosphate Binders
Calcium and Vitamin D Supplements
Antibiotics
Others Drugs
6.3. Global Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
6.4. Global Acute Renal Failure (ARF) Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Computed Tomography (CT) Scan
Kidney Biopsy
Ultrasound
6.5. Global Acute Renal Failure (ARF) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Hospitals
Home Healthcare
Others End-Users
6.6. Global Acute Renal Failure (ARF) Market, Sub-Segmentation Of Prerenal Acute Renal Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypovolemia
Decreased Cardiac Output
Renal Artery Stenosis
6.7. Global Acute Renal Failure (ARF) Market, Sub-Segmentation Of Renal Acute Renal Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Tubular Necrosis
Glomerulonephritis
Interstitial Nephritis
6.8. Global Acute Renal Failure (ARF) Market, Sub-Segmentation Of Postrenal Acute Renal Failure, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Obstructive Uropathy
Bladder Outlet Obstruction
Kidney Stones
7. Acute Renal Failure (ARF) Market Regional And Country Analysis
7.1. Global Acute Renal Failure (ARF) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Acute Renal Failure (ARF) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Acute Renal Failure (ARF) Market
8.1. Asia-Pacific Acute Renal Failure (ARF) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Acute Renal Failure (ARF) Market
9.1. China Acute Renal Failure (ARF) Market Overview
9.2. China Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Acute Renal Failure (ARF) Market
10.1. India Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Acute Renal Failure (ARF) Market
11.1. Japan Acute Renal Failure (ARF) Market Overview
11.2. Japan Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Acute Renal Failure (ARF) Market
12.1. Australia Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Acute Renal Failure (ARF) Market
13.1. Indonesia Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Acute Renal Failure (ARF) Market
14.1. South Korea Acute Renal Failure (ARF) Market Overview
14.2. South Korea Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Acute Renal Failure (ARF) Market
15.1. Western Europe Acute Renal Failure (ARF) Market Overview
15.2. Western Europe Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Acute Renal Failure (ARF) Market
16.1. UK Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Acute Renal Failure (ARF) Market
17.1. Germany Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Acute Renal Failure (ARF) Market
18.1. France Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Acute Renal Failure (ARF) Market
19.1. Italy Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Acute Renal Failure (ARF) Market
20.1. Spain Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Acute Renal Failure (ARF) Market
21.1. Eastern Europe Acute Renal Failure (ARF) Market Overview
21.2. Eastern Europe Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Acute Renal Failure (ARF) Market
22.1. Russia Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Acute Renal Failure (ARF) Market
23.1. North America Acute Renal Failure (ARF) Market Overview
23.2. North America Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Acute Renal Failure (ARF) Market
24.1. USA Acute Renal Failure (ARF) Market Overview
24.2. USA Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Acute Renal Failure (ARF) Market
25.1. Canada Acute Renal Failure (ARF) Market Overview
25.2. Canada Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Acute Renal Failure (ARF) Market
26.1. South America Acute Renal Failure (ARF) Market Overview
26.2. South America Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Acute Renal Failure (ARF) Market
27.1. Brazil Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Acute Renal Failure (ARF) Market
28.1. Middle East Acute Renal Failure (ARF) Market Overview
28.2. Middle East Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Acute Renal Failure (ARF) Market
29.1. Africa Acute Renal Failure (ARF) Market Overview
29.2. Africa Acute Renal Failure (ARF) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Acute Renal Failure (ARF) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Acute Renal Failure (ARF) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Acute Renal Failure (ARF) Market Competitive Landscape And Company Profiles
30.1. Acute Renal Failure (ARF) Market Competitive Landscape
30.2. Acute Renal Failure (ARF) Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Fresenius Medical Care AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
31. Acute Renal Failure (ARF) Market Other Major And Innovative Companies
31.1. Asahi Kasei Corporation
31.2. Baxter International Inc.
31.3. Astellas Pharma Inc.
31.4. Syensqo
31.5. Dr. Reddy's Laboratories Limited
31.6. Zydus Lifesciences Limited
31.7. NIKKISO Co., Ltd.
31.8. Quark Pharmaceuticals Inc.
31.9. NIPRO Corporation
31.10. Alloksys Life Sciences B.V.
31.11. AM-Pharma B.V.
31.12. Sentien Biotechnologies
31.13. MediBeacon LLC
31.14. Angion Biomedica Corp.
31.15. Atox Bio Ltd.
32. Global Acute Renal Failure (ARF) Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Acute Renal Failure (ARF) Market
34. Recent Developments In The Acute Renal Failure (ARF) Market
35. Acute Renal Failure (ARF) Market High Potential Countries, Segments and Strategies
35.1 Acute Renal Failure (ARF) Market In 2029 - Countries Offering Most New Opportunities
35.2 Acute Renal Failure (ARF) Market In 2029 - Segments Offering Most New Opportunities
35.3 Acute Renal Failure (ARF) Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings